TheraRadar
Data updated: Nov 8, 2026

KETOROLAC TROMETHAMINE AND PHENYLEPHRINE HYDROCHLORIDE (ketorolac tromethamine) · Lupin

Pain Approved 2019-07-01
FDA label not available. This product's label is not in FDA's label database (openFDA, DailyMed). Search DailyMed → · Drugs@FDA approval documents →
1
Indication
--
Phase 3 Trials
7
Years on Market

Details

Status
Prescription
First Approved
2019-07-01
Routes
IRRIGATION
Dosage Forms
SOLUTION

Companies

KETOROLAC TROMETHAMINE AND PHENYLEPHRINE HYDROCHLORIDE Approval History

2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
1 FDA actions from 2019 to 2019
Jul 2019 ORIGINAL
Update

What KETOROLAC TROMETHAMINE AND PHENYLEPHRINE HYDROCHLORIDE Treats

1 FDA approvals

Originally approved for its first indication in 2019 .

  • Other (1)
📋

Clinical Trial Registry

35 trials
Trial Sponsor ID Phase Status Title
NCT05324358 NTM-001-CT001 Ph 3 suspended Ketorolac Applied by Continuous IV Infusion for Treatment of Moderately Severe Postoperative Pain Following Bunionectomy
NCT06513208 HP-00109853 Ph 4 recruiting Ketorolac Effects on Post-operative Pain and Lumbar Fusion
NCT05641363 KETODOSE KETODOSE20221107 Ph 3 completed Comparison of Ketorolac at Three Doses in Children With Acute Pain
NCT03913702 results posted UTMB IRB #: 18-0156 Ph 2 terminated Subacromial Methylprednisolone Versus Ketorolac for Shoulder Impingement
NCT03453541 4923 Ph 4 terminated Ketorolac Use in Pediatric Patients Undergoing Tonsillectomy
NCT04733326 CairoU0 Ph 1 completed Evaluation of Post-operative Pain and Expression of IL-8 Using Ketolac or Cryoirrigation as a Final Flush in Single Visit Endodontic Treatment in Teeth With Symptomatic Irreversible Pulpitis and Apical Periodontitis.Randomized Clinical Trial.
NCT06395428 WMed-2024-1032 Ph 4 recruiting Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency Department
NCT06160778 KETOAPP 23-0952 Ph 3 recruiting Intravenous Ketorolac Vs. Morphine In Children With Acute Abdominal Pain
NCT04666701 EMS1319 - ESCÓCIA Ph 2 withdrawn Efficacy and Safety of Escócia Association in the Treatment of Acute Pain
NCT05382546 NTM-001-AHC001 Ph 1 completed A Pharmacokinetic Study of Intravenous NTM-001 in Healthy Chinese Subjects
NCT04439396 19-387 Ph 1 completed Toradol (Ketorolac) in Breast Surgery to Reduce Pain & Opioid Use
NCT04554862 M419 Ph 4 completed The Analgesic Efficacy of Magnesium and Ketorolac in Ultrasound Supraclavicular Block
NCT04939987 IRB00074034 Ph 2, Ph 3 withdrawn Opioid-Free Pain Control Regiment Following Robotic Radical Prostatectomy
NCT01471899 CTRGEMS0611 Ph 3 completed Comparison Of Ketorolac Tromethamine Oral Drops Versus Naproxen For Moderate to Severe Back Pain Treatment
NCT01471886 CTREMS0611 Ph 3 completed Comparison Of Ketorolac Tromethamine Versus Naproxen For Moderate to Severe Back Pain Treatment
NCT02902770 results posted 2016-03-09 Ph 4 completed Intravenous Lidocaine and Ketorolac for Pain Management
NCT02923687 AZadUMS-P/190/D Ph 2 completed Premedication Efficacy of Ketorolac Infiltration on Post Endodontic Pain
NCT03410212 IANB IR.IAU.DENTAL.REC.1396,31 Ph 2 completed Efficacy of Block Injection of an Anti Inflammatory Medicine in Patients With Mandibular Dental Pain
NCT02658149 results posted 2015-422 Ph 4 completed Psoas Compartment Block Versus Periarticular Local Anesthetic for Total Hip Arthroplasty
NCT02313675 results posted PRO14110464 Ph 4 completed Pain Outcomes of Intra-operative IV Tylenol and/or IV Toradol for Carpal Tunnel and Distal Radius Fracture Surgeries
NCT03007381 KANGAROO KANGAROO Ph 4 withdrawn Ketorolac for Analgesia followiNG Autologous Breast RecOnstructiOn
NCT02638831 DRL_RUS/PMS/2012/KETG Ph 4 completed Ketorol Gel in Gonarthrosis and Low Back Pain
NCT02729285 2014MEKY042 Ph 4 completed Preoperative Ketorolac for Pain Control in Scleral Buckle Surgery
NCT02601911 AzadUMS P/66/D Ph 2 completed Effect of Premedication on Success of Inferior Alveolar Nerve Block Injection
NCT02614118 AZadUMS-P/139/D Ph 2 completed Premedication Efficacy of Oral Ketorolac and Ketorolac/ Acetaminophen on Post Treatment Pain
NCT02536430 AZadUMS-P/212/D Ph 2 completed Efficacy of Ketorolac Buccal Infiltration on Success Rate of Inferior Alveolar Nerve Block
NCT00907114 HJM 1667/09.03.24 Ph 2 completed Topic Ketorolac Added to Panphotocoagulation in Proliferative Diabetic Retinopathy
NCT01596166 EDMigraine-4 EDMIGR-004-01 Ph 4 completed Intravenous Ketorolac and Metoclopramide for Pediatric Migraine in the Emergency Department
NCT01542190 0018014600011 Ph 4 completed Comparison of Topical Ketorolac 0,4% Versus Placebo in Cataract Surgery
NCT02000401 0703-2012-SPRIX Ph 4 completed Intranasal Ketorolac Tromethamine (Sprix) for Acute Pain of Interstitial Cystitis Flare of Pain
NCT01365624 results posted ROX 2007-02 Ph 1 completed Safety and Pharmacokinetics Study of Intranasal Ketorolac in Elderly and Nonelderly Adult Healthy Subjects
NCT01436032 N1539-05 Ph 3 terminated Efficacy, Safety and Tolerability Study of N1539 in Subjects After Abdominal Laparoscopic Surgery
NCT01291472 3214 2011-000367-27 Ph 4 completed Disposition of Intravenous Ketorolac
NCT01015235 KAI-1678-002 Ph 2 completed Safety and Efficacy Study of KAI-1678 to Treat Subjects With Postoperative Pain
NCT01021761 results posted 2009 0199 Ph 4 completed A Comparison of Prostaglandin E2 (PGE2) Inhibition of Acuvail(Ketorolac 0.45%), Xibrom (Bromfenac 0.09%)and Nevanac (Nepafenac)in Patients Undergoing Phacoemulsification
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

KETOROLAC TROMETHAMINE AND PHENYLEPHRINE HYDROCHLORIDE FDA Label Details

FDA label not available. This product's label is not in FDA's label database (openFDA, DailyMed). Search DailyMed → · Drugs@FDA approval documents →

Track KETOROLAC TROMETHAMINE AND PHENYLEPHRINE HYDROCHLORIDE with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.